Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




PEF Cardiac Ablation System Reduces Collateral Damage

By HospiMedica International staff writers
Posted on 21 Oct 2020
An innovative cardiac ablation system utilizes high voltage, high frequency, pulsed electric field (PEF) energy to ablate tissue.

The Galaxy Medical (San Carlos, CA, USA) Centauri System is an open energy platform that uses PEF technology to improve the safety and efficacy of cardiac ablation by reducing unintentional conductive heating or cooling of extracardiac structures, such as the esophagus, phrenic nerve, and airway. More...
Efficacy is enhanced by creation of full-thickness, transmural lesions, as therapeutic doses of PEF energy are limited to the myocardium. Hardware and waveform control algorithms enable electrophysiologists to continue with their established point-by-point clinical workflow, as used in the majority of cardiac ablation procedures.

Key features of the Centauri System include a proprietary user interface; plug and play interfacing with all cardiac mapping and navigation systems; no-compromise compatibility with market-released focal and contact-force sensing catheters; choice of dose settings when treating variable tissue thickness; a proprietary technology that completely eliminates microbubbles (which may cause cerebral or coronary air emboli during PEF delivery); and automated voltage control to prevent both over- and under-dosing. A multicenter trial, the ECLIPSE-AF study, is underway to assess the safety and efficacy of the Centauri System

“Our research has consistently demonstrated that PEF with focal catheters yields predictable and transmural lesions, as opposed to inconsistent ablation depth and intermittent electrical stunning associated with multipolar catheters with variable contact,” said Jonathan Waldstreicher, MD, CEO of Galaxy Medical. “We look forward to completing enrollment of the ECLIPSE-AF study and sharing the clinical experience in the near future.”

“The Galaxy Medical Centauri System operated seamlessly within my atrial fibrillation ablation clinical workflow,” said Ante Anić, MD, electrophysiology lab director at University Hospital Split (Croatia), and primary investigator of the ECLIPSE-AF study. “PEF energy is the future of electrophysiology, and Centauri allowed me to deliver it with a standard focal ablation technique to patients under conscious sedation, and without compromising on the ablation catheter, contact force feedback, or cardiac mapping system.”

Cardiac catheter ablation procedures are used to treat a variety of cardiac arrhythmias, especially supraventricular tachyarrhythmias such as atrial fibrillation (AF), atrial flutter, and atrial tachycardia. The procedures involve advancing a catheter into the heart and selectively ablating certain areas of tissue in order to prevent the spread of the electrical signals that give rise to the arrhythmia.

Related Links:
Galaxy Medical


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.